Subscribe
31 July 2025NewsAmericasSteve Trybus, Troutman Pepper Locke | Jennifer Burdman, Sauvegarder Investment Management | Elbert Chiang, Beam Therapeutics | Mark Jackson, Editas Med | Lillian Hiett, Takeda

WATCH: Beyond patents — the evolving role of IP lawyers in life sciences

This LSPN panel brings together experts from Troutman Pepper Locke, Sauvegarder Investment Management, Beam Therapeutics, Editas Med, and Takeda to explore the expanding role of IP lawyers in the life sciences industry.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk




Editor's picks

BMS blocks biosimilar version of blockbuster cancer drug in India
Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025

Editor's picks

Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025
Africa
Explainer: ARIPO’s role in Plant Variety Protection
15 July 2025
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

More features

Teva draws line under asthma inhaler feud with US rival
Xanax owner fends off ‘Canvax’ mark in EU
Four-lawyer team joins Cozen O’Connor’s new San Diego office
Could Apple v Masimo limit patent cases at the ITC?
Eli Lilly strikes again in weight-loss drugs fight
Novartis moves to block cancer drug generic in US
WATCH: China patent landscape—AI, patent linkage, export controls, and more
China bars USPTO employee from leaving country